Home | Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II.

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. has only one revision
RevisionStatus
Saved 19/07/2023 - 3:55pm by Gladyscurrent revision (published)